metastatic squamous cell anal carcinoma research hub

SPARTANA : Spartalizumab, mDCF (docetaxel, cisplatin and 5-fluorouracil) and radiotherapy in patients with metastatic squamous cell anal carcinoma. A Phase IIA study

This study is testing new treatments for a type of cancer called anal cancer that has spread. It combines existing chemotherapy with an investigational drug and radiotherapy to see if patients live longer without their cancer getting worse.